CLEMENS, Wendy L.,ZALEVSKY, Jonathan,HOCH, Ute,TAGLIAFERRI, Mary
申请号：
AU2018360790
公开号：
AU2018360790A1
申请日:
2018.11.06
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
This disclosure provides methods for treating a tumor in a subject comprising administering to the subject an anti-PD-1 antibody and a CD-122-biased agonist. In some embodiments, the tumor is derived from a melanoma, a renal cell carcinoma (RCC), a non-small cell lung carcinoma (NSCLC), a urothelial cancer (UC), a breast cancer, or any combination thereof.
